CONtrolled Focal Fibrous Band Release Method Study

Completed · Not applicable

Conditions studied: Cellulite

In brief

Study to evaluate the safety and effectiveness of the Avéli medical device to reduce the appearance of cellulite.

Key facts

Study ID

NCT04743635

Run by

Revelle Aesthetics, Inc

People needed

74

Starts

2021-01-07

Expected to finish

2022-03-04

Last updated by the study team

2023-06-06

Who can join

Age: 21 and older, up to 55. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Moderate to severe cellulite

You may not qualify if…

• Body Mass Index ≥30.0

Where it is running

• Clinical Site #3 — Los Angeles, California, United States
• Clinical Site #5 — San Diego, California, United States
• Clinical Site #4 — San Francisco, California, United States
• Clinical Site #2 — Coral Gables, Florida, United States
• Clinical Site #6 — Shreveport, Louisiana, United States
• Clinical Site #8 — Chestnut Hill, Massachusetts, United States
• Clinical Site #1 — Minneapolis, Minnesota, United States
• Clinical Site #7 — Southport, Queensland, Australia
• Clinical Site #9 — Toowoomba, Queensland, Australia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.